Abbott Slaps Watson With Patent Suit Over Niaspan Generic
Watson Pharmaceuticals Inc. was the latest generic drug maker to be hit with a patent suit over Abbott Laboratories unit AbbVie Inc.'s ongoing legal battle to shield its cholesterol drug Niaspan...To view the full article, register now.
Already a subscriber? Click here to view full article